Bahrain approves vaccination for adolescents aged 12 to 17 and a booster dose for people over fifty

Bahrain approves vaccination for adolescents aged 12 to 17 and a booster dose for people over fifty

The National Medical Taskforce for Combatting the Coronavirus (COVID-19) announced that members of the Ministry of Health’s Vaccination Committee have agreed to the vaccination of adolescents aged 12 to 17, with two doses of the Pfizer-BioNTech vaccine. The decision was made after the Committee studied all the recommendations issued by the World Health Organization’s Strategic Advisory Group of Experts on Immunization, and the United States of America’s Center for Disease Control, to ensure adolescents strengthen their immunity against the virus. The Taskforce noted that the opening of the vaccination registration for adolescents on healthalert.gov.bh will be announced soon, adding that an approval from a guardian is needed when visiting the health centres, in addition to the presence of a guardian when taking the vaccine. Furthermore, the Taskforce also announced the opening of registration for a booster COVID-19 vaccine dose for the most vulnerable groups in Bahrain, at least 6 months after taking the second dose of the Sinopharm vaccine, for first responders, as well as citizens and residents above the age of 50, as well as those suffering from obesity, low immunity, or other underlying health conditions. The Taskforce indicated that registration for the booster dose will be available through